ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 179 filers reported holding ARCUS BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 2.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,304,000 | +5.5% | 72,994 | +35.2% | 0.00% | 0.0% |
| Q4 2021 | $2,184,000 | +109.4% | 53,976 | +80.4% | 0.00% | 0.0% |
| Q3 2021 | $1,043,000 | +27.5% | 29,917 | +0.5% | 0.00% | – |
| Q2 2021 | $818,000 | -15.9% | 29,772 | -14.1% | 0.00% | -100.0% |
| Q1 2021 | $973,000 | +27.9% | 34,645 | +18.2% | 0.00% | – |
| Q4 2020 | $761,000 | +107.9% | 29,310 | +37.4% | 0.00% | – |
| Q3 2020 | $366,000 | -71.1% | 21,337 | -58.3% | 0.00% | -100.0% |
| Q2 2020 | $1,267,000 | +448.5% | 51,206 | +208.1% | 0.00% | – |
| Q1 2020 | $231,000 | – | 16,622 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |